Ovid Therapeutics (OVID)
(Delayed Data from NSDQ)
$3.28 USD
-0.05 (-1.36%)
Updated May 16, 2024 04:00 PM ET
After-Market: $3.27 -0.01 (-0.15%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/2/24 |
---|---|
Current Quarter | -0.23 |
EPS Last Quarter | -0.17 |
Last EPS Surprise | 26.09% |
ABR | 1.22 |
Earnings ESP
|
-4.24% |
---|---|
Current Year | -0.72 |
Next Year | -0.45 |
EPS (TTM) | -0.73 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.11M | 0.11M | 3.59M | 20.34M |
# of Estimates | 4 | 4 | 5 | 4 |
High Estimate | 0.17M | 0.20M | 16.30M | 33.06M |
Low Estimate | 0.08M | 0.05M | 0.15M | 0.79M |
Year ago Sales | 0.08M | 0.11M | 0.39M | 3.59M |
Year over Year Growth Est. | 40.00% | 1.82% | 816.09% | 466.33% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.23 | -0.23 | -0.72 | -0.45 |
# of Estimates | 6 | 5 | 7 | 6 |
Most Recent Consensus | -0.22 | -0.22 | -0.79 | -0.81 |
High Estimate | -0.18 | -0.18 | -0.04 | 1.01 |
Low Estimate | -0.28 | -0.29 | -1.07 | -0.99 |
Year ago EPS | -0.18 | -0.16 | -0.74 | -0.72 |
Year over Year Growth Est. | -27.78% | -43.75% | 2.70% | 37.60% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 1 | 1 | 0 |
Down Last 7 Days | 1 | 1 | 3 | 3 |
Down Last 30 Days | 1 | 1 | 3 | 3 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.23 | -0.23 | -0.72 | -0.45 |
7 Days Ago | -0.23 | -0.23 | -0.73 | -0.38 |
30 Days Ago | -0.21 | -0.20 | -0.65 | -0.20 |
60 Days Ago | -0.22 | -0.21 | -0.64 | -0.10 |
90 Days Ago | -0.17 | -0.18 | -0.43 | -0.60 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.24 | -0.24 | -0.83 | -0.74 |
Zacks Consensus Estimate | -0.23 | -0.23 | -0.72 | -0.45 |
Earnings ESP | -4.24% | -3.98% | -15.74% | -65.39% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.17 | -0.22 | -0.16 | -0.18 | NA |
Estimate | -0.23 | -0.17 | -0.18 | -0.21 | NA |
Difference | 0.06 | -0.05 | 0.02 | 0.03 | 0.02 |
Surprise | 26.09% | -29.41% | 11.11% | 14.29% | 5.52% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more